Genocea Biosciences
Genocea Biosciences
Harnessing the power of T cells.
Human health & social work | Global | Access to Information |
Profile Provided By: Company Website
Overview
Genocea finds targets of T cell responses to discover and develop life changing medicines.We ve created a pipeline of novel vaccine and immunotherapy programs that stimulate the T cell arm of the immune system which is increasingly recognized as critical to generating protective immune responses against a wide array of diseases.Genocea's pipeline of novel T cell vaccines includes GEN 003 for HSV 2 therapy and GEN 004 a protein vaccine directed at pneumococcus both currently in Phase II clinical trials.
Industry |
Legal Structure |
Operating Status |
Employees |
Human health & social work | Operating | 51 - 200 employees |
Funding and Financing Rounds
Sep, 2012 / Series C + / PRI / Equity
Team
Impact
Geographies:
Social Objectives:
Environmental Objectives:
Operational Impact:
- Social Policies and Performance
Impact Reports & Metrics
Offices
Headquarters
100 Acorn Park Drive Floor 5
Cambridge, Massachusetts 02140
United States of America